< All Topics
Print

Palm Oil and Human Health: Evidence on Cholesterol, Nutrition, and Food Safety

Key Points: Palm Oil and Health
  • Palm oil contains both saturated and unsaturated fatty acids; its effect on blood lipids depends on what it replaces and the overall diet—not simply on the oil’s name.[1][2]
  • Clinical trials have found higher LDL when palm oil replaces oils richer in unsaturated fats, while other reviews report different results depending on the comparator.[1][2][3]
  • WHO recommends keeping saturated fat at no more than 10% of total energy, replacing it mainly with unsaturated fats or fibre-rich carbohydrate foods.[4]
  • 3-MCPDE and glycidyl esters may form during high-temperature refining. This is a process-contaminant issue requiring controls, not proof that all palm oil causes cancer.[7][8][10]

Palm oil is often discussed in absolute terms: some claims portray it as invariably harmful, while others describe it as wholly beneficial. The evidence supports neither extreme. Health assessment must distinguish fatty-acid composition, what the oil replaces, amount and dietary pattern, product type (refined palm oil or red palm oil), and processing and heating conditions.

What is palm oil?

Palm oil is obtained from the mesocarp (the fleshy part) of the oil-palm fruit (Elaeis guineensis), whereas palm-kernel oil comes from the seed. This article concerns mesocarp oil, not palm-kernel oil. Composition and quality vary with variety, ripeness, extraction, fractionation and refining.[14]

Palm oil is not a single substance. It is a mixture of triglycerides containing saturated and unsaturated fatty acids, together with minor components. Its use in cooking oil, margarine, shortening and processed foods reflects technological properties; use alone does not establish clinical benefit or harm.[14]

Fat composition and differences among palm-oil fractions

Ordinary palm oil contains mainly palmitic acid (saturated) and oleic acid (monounsaturated), as well as linoleic acid (polyunsaturated). A review of cooking-oil composition reported general ranges of about 39.3–47.5% palmitic, 36–44% oleic and 9–12% linoleic acid. These figures describe fatty-acid composition and vary by sample and processing.[14]

Palm olein is the liquid fraction obtained by fractionation, while palm stearin is more solid. Red palm oil or virgin palm oil differs from fully refined oil: gentler processing can retain more carotenoids, but results from a particular experiment should not be treated as representative of every product.[16]

Palm products relevant to nutrition discussions
Product Main distinction Interpretation note
Palm oil (CPO/RBDPO) From the fruit mesocarp; RBDPO has been refined, bleached and deodorized. Minor components and quality depend on processing.
Palm olein Liquid fraction of palm oil after fractionation. Its composition is not identical to every other palm-oil product.
Red palm oil / VPO Gentler processing may retain carotenoids. Content depends on processing; it is not evidence of a treatment or substitute for medicine.
Palm-kernel oil Obtained from the seed, not the fleshy fruit; its fatty-acid profile differs. Not the oil discussed here.

How does palm oil affect cholesterol?

The answer depends on the comparator. A 2015 meta-analysis of clinical trials by Sun and colleagues found that, compared with vegetable oils low in saturated fat, palm oil was associated with a mean LDL difference of +0.24 mmol/L (95% CI 0.13–0.35); among randomized trials, the difference was +0.31 mmol/L. HDL was also slightly higher. This compares replacing one type of fat with another, not an absolute effect across all diets.[1]

A 2019 meta-analysis by Wang and colleagues comparing palm-oil-rich diets with diets rich in unsaturated fatty acids found an HDL increase of 0.15 mmol/L, with no statistically significant differences in total cholesterol, LDL or triglycerides. The authors noted that larger intervention trials are needed.[2]

The WHO’s 2024 overview found that results across reviews varied with comparator oils and methods. It also noted that direct evidence on cardiovascular outcomes is limited. Thus, claims that palm oil always raises cholesterol—or has no effect at all—oversimplify the evidence.[3][5]

Examples of clinical-trial meta-analysis findings—not predictions for every individual
Review and comparator Main finding Important limitation
Sun et al. (2015): vegetable oils low in saturated fat LDL +0.24 mmol/L; randomized trials +0.31 mmol/L; HDL +0.02 mmol/L. Mean effects across studies; initial heterogeneity was high.
Wang et al. (2019): unsaturated fatty acids LDL −0.05 mmol/L (not significant); HDL +0.15 mmol/L. 11 articles; evidence is limited and authors called for larger trials.
WHO (2024): comparison across reviews Total-cholesterol and LDL results varied with the comparator and method. WHO did not assess certainty of evidence; this is not a palm-oil-specific guideline.
“Not statistically significant” does not prove that every effect is zero. Results using different comparators and samples should not be treated as directly interchangeable.

Palm oil and heart disease: what is known?

Changes in LDL are a cardiovascular risk marker, but dietary trials lasting several weeks are not the same as long-term studies measuring heart attacks or deaths. A 2018 systematic review by Ismail and colleagues concluded that the available evidence was insufficient to establish a strong causal relationship between palm-oil consumption and cardiovascular events or mortality.[3]

The WHO’s 2024 overview summarized studies with mixed results. One observational analysis reported odds of 1.26 for nonfatal myocardial infarction; a finding from one review does not prove that palm oil itself causes heart attacks. WHO highlighted limitations in the evidence and differences among comparators.[5]

A cautious summary is that some biomarker trials show LDL can fall when palm oil is replaced with oils rich in unsaturated fats, while direct evidence on long-term heart-disease outcomes remains limited and inconsistent.[1][3][5]

Saturated fat and WHO guidance

WHO (2023) recommends that saturated fat provide no more than 10% of daily energy for adults and children aged two years and older. Dietary fat should come primarily from unsaturated fatty acids. Preferred replacements include polyunsaturated fats, plant-source monounsaturated fats, or carbohydrates from naturally fibre-rich foods such as whole grains, vegetables, fruit and pulses.[4]

The 10% limit applies to total saturated fat in the overall diet, not to palm oil specifically. Assessment should consider all sources of saturated fat, portion size, energy needs and replacement foods; replacing saturated fat with sugar or refined starch is not WHO’s recommendation.[4]

Is red palm oil a source of vitamin A?

Carotenoids give red palm oil its orange-red colour, and some can be converted by the body into vitamin A. In one study producing cold-pressed virgin palm oil, measured carotenoid content was 708 µg/g, compared with 343 µg/g in the CPO sample from that same study. These values come from specific experimental conditions and are not universal product values.[16]

Refining and heating can reduce carotenoids and tocopherols/tocotrienols. A CPO storage study reported declines in minor components under heated conditions, showing that content depends on processing and storage.[17]

Red palm oil is not a medicine or a replacement for healthcare in vitamin A deficiency. Nutrient content alone does not prove disease prevention or treatment.[5][6]

Diabetes, body weight and claims of special benefits

A 2019 systematic review of eight intervention studies found no significant differences in fasting glucose or insulin when palm-oil/palm-olein-rich diets were compared with several other vegetable oils. The studies lasted about 3–7 weeks and mainly involved healthy participants, not people with diabetes; the evidence does not support claims that palm oil prevents or treats diabetes.[15]

A small clinical trial in 40 adults found no significant change in body weight or BMI after an eight-week palm-oil intervention. A 2024 network meta-analysis found higher body weight with palm oil than with canola oil, but the certainty was low; a network result does not prove that palm oil alone causes weight gain.[18][19]

Oil is energy-dense. Amount consumed, the overall diet and energy balance matter more than claims that one oil automatically makes a person gain or lose weight. Evidence does not support promoting palm oil as a metabolic treatment.[6][19]

Process contaminants: 3-MCPDE and glycidyl esters

3-MCPD esters (3-MCPDE) and glycidyl esters (GE) can form unintentionally during high-temperature oil refining. EFSA reported that the highest observed levels were in palm oils/fats, but these contaminants also occur in other vegetable oils and processed foods; their formation is related to processing conditions.[7]

EFSA assessed glycidol (the parent compound of GE) as genotoxic and carcinogenic based on toxicological evidence, mainly experimental, and did not set a safe intake level for GE. For 3-MCPD and its esters, EFSA set a tolerable daily intake of 2 µg/kg body weight per day in 2018. A hazard assessment of a process contaminant is not the same as evidence that ordinary palm-oil consumption has been shown to cause cancer in humans.[7][8]

The European Union sets maximum levels for certain food categories under Regulation (EU) 2020/1322; those limits are not universal and are not automatically Indonesian regulations.[9]

A 2023 review by Elisabeth discusses mitigation in Indonesia, including reducing chloride precursors, optimizing bleaching and deodorization, and using adsorbents. Codex CXC 79-2019 also provides a code of practice to reduce formation of 3-MCPDE and GE along the production chain.[10][11]

Two process contaminants that are often conflated
Compound Formation and toxicological concern Meaning for consumers
3-MCPDE Forms mainly through reactions involving chloride precursors and oil components during high-temperature refining; EFSA TDI for 3-MCPD and its esters is 2 µg/kg body weight/day. A TDI is a chronic-exposure reference, not a threshold for inferring harm from a single meal.
Glycidyl esters (GE) Can form during high-temperature refining. EFSA considers glycidol genotoxic and carcinogenic in its hazard assessment and did not set a safe intake. Actual risk depends on contaminant levels and exposure; process control and monitoring are important.
EFSA assessed hazards and exposure in European populations. This should not be restated as a claim that all palm oil is harmful or that ordinary consumption has been proven to cause cancer in humans.

Heating and repeated use of frying oil

Prolonged heating, high temperatures, oxygen, food residues and repeated frying cycles can cause oxidation, hydrolysis and polymerization in different oils. Used oil may change in colour, odour, flavour and chemical properties; deterioration depends on use conditions, not only on the plant source.[14]

Under some conditions palm oil is more oxidation-stable than oils richer in polyunsaturated fatty acids, but it is not immune to deterioration. Temperature, duration, food type and oil-replacement practices affect degradation.[14]

How to evaluate health claims critically

Check whether a claim comes from a human clinical trial, systematic review, animal study or chemical test. Carotenoid content does not automatically prove disease prevention; finding process contaminants does not mean every product contains harmful levels.

Ask which oil was used as the comparator, how long the study lasted, how many people participated, which palm product was tested, and whether the outcome was a biomarker or a clinical event. For individual conditions—including high cholesterol, heart disease, diabetes or infant nutrition—follow health-professional advice and dietary guidelines.

Conclusion

Palm oil is neither a medicine nor a substance with identical effects in everyone. Some trials find higher LDL than with vegetable oils richer in unsaturated fats; other reviews report smaller or nonsignificant findings depending on the comparator. Direct evidence on long-term heart-disease outcomes remains limited.

The most consistent public-health advice is to limit total saturated fat, choose unsaturated-fat sources within a balanced diet, and consider portion size. Controlling process contaminants and avoiding excessive or prolonged oil heating are also important for food safety.

References

  1. Sun, Y., Neelakantan, N., Wu, Y., Lote-Oke, R., Pan, A., & van Dam, R. M. (2015). Palm oil consumption increases LDL cholesterol compared with vegetable oils low in saturated fat in a meta-analysis of clinical trials. The Journal of Nutrition, 145(7), 1549–1558. DOI: 10.3945/jn.115.210575. PubMed.
  2. Wang, F., Zhao, D., Yang, Y., & Zhang, L. (2019). Effect of palm oil consumption on plasma lipid concentrations related to cardiovascular disease: A systematic review and meta-analysis. Asia Pacific Journal of Clinical Nutrition, 28(3), 495–506. DOI: 10.6133/apjcn.201909_28(3).0009. PubMed.
  3. Fattore, E., Bosetti, C., Brighenti, F., Agostoni, C., & Fattore, G. (2014). Palm oil and blood lipid-related markers of cardiovascular disease: A systematic review and meta-analysis of dietary intervention trials. The American Journal of Clinical Nutrition, 99(6), 1331–1350. DOI: 10.3945/ajcn.113.081190. PubMed.
  4. World Health Organization. (2023). Saturated fatty acid and trans-fatty acid intake for adults and children: WHO guideline. ISBN 978-92-4-007363-0. WHO.
  5. World Health Organization. (2024). A rapid overview of systematic reviews on the effects of palm oil intake compared with intake of other vegetable oils on mortality and cardiovascular health in children and adults. ISBN 978-92-4-008834-4. WHO; WHO IRIS.
  6. Unhapipatpong, C., Chattranukulchai Shantavasinkul, P., Kasemsup, V., et al. (2021). Tropical oil consumption and cardiovascular disease: An umbrella review of systematic reviews and meta-analyses. Nutrients, 13(5), 1549. DOI: 10.3390/nu13051549. PMC.
  7. EFSA CONTAM Panel. (2016). Risks for human health related to the presence of 3- and 2-monochloropropanediol (MCPD), their fatty acid esters, and glycidyl fatty acid esters in food. EFSA Journal, 14(5), 4426. DOI: 10.2903/j.efsa.2016.4426. Ringkasan EFSA.
  8. EFSA CONTAM Panel. (2018). Update of the risk assessment on 3-monochloropropane diol and its fatty acid esters. EFSA Journal, 16(1), 5083. DOI: 10.2903/j.efsa.2018.5083. Ringkasan EFSA.
  9. European Commission. (2020). Commission Regulation (EU) 2020/1322 amending Regulation (EC) No 1881/2006 as regards maximum levels of 3-MCPD, 3-MCPD fatty acid esters and glycidyl fatty acid esters in certain foods. EUR-Lex.
  10. Elisabeth, J. (2023). Mitigation of 3-MCPDE and GE in palm oil in Indonesia. Menara Perkebunan, 91(2). DOI: 10.22302/iribb.jur.mp.v91i2.549. Artikel.
  11. World Health Organization. (2019). Code of practice for the reduction of 3-monochloropropane-1,2-diol esters (3-MCPDEs) and glycidyl esters (GEs) in refined oils and food products made with refined oils (CXC 79-2019). Codex Alimentarius.
  12. Hormenu, T., Salifu, I., Paku, J. E., et al. (2024). Tropical oils consumption and health: A scoping review to inform the development of guidelines in tropical regions. BMC Public Health, 24, 2468. DOI: 10.1186/s12889-024-19949-x. PMC.
  13. Abrante-Pascual, S., Nieva-Echevarría, B., & Goicoechea-Oses, E. (2024). Vegetable oils and their use for frying: A review of their compositional differences and degradation. Foods, 13(24), 4186. DOI: 10.3390/foods13244186. PMC.
  14. Elisabeth, J. (2023). Mitigation of 3-MCPDE and GE in palm oil in Indonesia. Menara Perkebunan, 91(2). DOI: 10.22302/iribb.jur.mp.v91i2.549. Artikel.
  15. Abrante-Pascual, S., Nieva-Echevarría, B., & Goicoechea-Oses, E. (2024). Vegetable oils and their use for frying: A review of their compositional differences and degradation. Foods, 13(24), 4186. DOI: 10.3390/foods13244186. PMC.
  16. Ismail, S. R., Maarof, S. K., Siedar Ali, S., & Ali, A. (2019). Effects of palm oil consumption on biomarkers of glucose metabolism: A systematic review. PLoS ONE, 14(8), e0220877. DOI: 10.1371/journal.pone.0220877. PMC.
  17. Hassan, N. S. M., Hossain, M. S., Balakrishnan, V., et al. (2021). Influence of fresh palm fruit sterilization in the production of carotenoid-rich virgin palm oil. Foods, 10(11), 2838. DOI: 10.3390/foods10112838. PMC.
  18. Tan, C.-H., Ariffin, A. A., Ghazali, H. M., Tan, C.-P., Kuntom, A., & Choo, A. C.-Y. (2017). Changes in oxidation indices and minor components of low free fatty acid and freshly extracted crude palm oils under two different storage conditions. Journal of Food Science and Technology, 54(7), 1757–1764. DOI: 10.1007/s13197-017-2569-9. PMC.
  19. Swarnamali, H., Ranasinghe, P., & Jayawardena, R. (2024). The effect of coconut oil and palm oil on anthropometric parameters: A clinical trial. BMC Nutrition, 10, 9. DOI: 10.1186/s40795-023-00812-y. PMC.
  20. Abdollahi, S., Soltani, S., Ramezani-Jolfaie, N., et al. (2024). The effect of different edible oils on body weight: A systematic review and network meta-analysis of randomized controlled trials. BMC Nutrition, 10, 107. DOI: 10.1186/s40795-024-00907-0. PMC.
  21. Abdollahi, S., Soltani, S., Ramezani-Jolfaie, N., et al. (2024). The effect of different edible oils on body weight: A systematic review and network meta-analysis of randomized controlled trials. BMC Nutrition, 10, 107. DOI: 10.1186/s40795-024-00907-0. PMC.
Table of Contents